{"product_id":"5-amino-1mq","title":"5-AMINO-1MQ","description":"\u003cp class=\"PDq2pG_selectionAnchorContainer\"\u003e5-Amino-1MQ is a\u003cstrong\u003e research compound\u003c\/strong\u003e that inhibits an enzyme called \u003cstrong\u003enicotinamide N-methyltransferase (NNMT)\u003c\/strong\u003e. \u003cspan class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eWhat is NNMT?\u003c\/h3\u003e\n\u003cp\u003eNNMT is an enzyme involved in energy metabolism. Higher NNMT activity has been associated in research with:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eObesity\u003c\/li\u003e\n\u003cli\u003eInsulin resistance\u003c\/li\u003e\n\u003cli\u003eType 2 diabetes\u003c\/li\u003e\n\u003cli\u003eFatty liver disease\u003c\/li\u003e\n\u003cli\u003eSome cancers\u003c\/li\u003e\n\u003cli\u003eAge-related metabolic dysfunction\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe theory is that inhibiting NNMT may allow cells to use energy more efficiently and improve metabolic health.\u003c\/p\u003e\n\u003ch3\u003eWhat is 5-Amino-1MQ studied for?\u003c\/h3\u003e\n\u003cp\u003eResearchers have investigated it for several potential effects:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e1. Fat loss (most common area of research)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eIncreased fat burning\u003c\/li\u003e\n\u003cli\u003eReduced fat storage\u003c\/li\u003e\n\u003cli\u003eDecreased body fat in obese animal models\u003c\/li\u003e\n\u003cli\u003ePreservation of lean muscle during weight loss\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e2. Improved insulin sensitivity\u003c\/strong\u003e\u003cbr\u003eAnimal studies suggest it may improve glucose metabolism and reduce insulin resistance.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e3. Fatty liver\u003c\/strong\u003e\u003cbr\u003eSome research suggests NNMT inhibition may reduce liver fat accumulation.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e4. Cellular energy\u003c\/strong\u003e\u003cbr\u003eMay increase NAD+ availability and improve mitochondrial function, although this is still being investigated.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e5. Aging research\u003c\/strong\u003e\u003cbr\u003eBecause NNMT influences NAD+ metabolism, it has attracted interest in longevity research, but there is no evidence that it extends lifespan in humans.\u003c\/p\u003e\n\u003ch3\u003eHuman evidence\u003c\/h3\u003e\n\u003cp\u003eThere are currently \u003cstrong\u003every limited human clinical data\u003c\/strong\u003e. Most claims made online about dramatic fat loss are based on:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eMouse studies\u003c\/li\u003e\n\u003cli\u003eCell culture research\u003c\/li\u003e\n\u003cli\u003eAnecdotal reports\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThere is not enough evidence to know:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe most effective dose\u003c\/li\u003e\n\u003cli\u003eLong-term safety\u003c\/li\u003e\n\u003cli\u003eSide effects over months or years\u003c\/li\u003e\n\u003cli\u003eDrug interactions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eCommon research stacks\u003c\/h3\u003e\n\u003cp\u003eAmong researchers and experimental users, 5-Amino-1MQ is often combined with compounds aimed at body composition:\u003c\/p\u003e\n\u003cdiv class=\"group TyagGW_tableContainer\"\u003e\n\u003cdiv class=\"TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth class=\"last:pe-10\"\u003eCompound\u003c\/th\u003e\n\u003cth class=\"last:pe-10\"\u003eReason for stacking\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTirzepatide\u003c\/td\u003e\n\u003ctd\u003eAppetite suppression plus potential increase in fat oxidation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetatrutide\u003c\/td\u003e\n\u003ctd\u003eSimilar rationale with greater weight-loss potential\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCagrilintide\u003c\/td\u003e\n\u003ctd\u003eAdditional appetite reduction\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTesamorelin\u003c\/td\u003e\n\u003ctd\u003eInvestigated for reducing visceral fat while preserving muscle\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMOTS-c\u003c\/td\u003e\n\u003ctd\u003eExperimental mitochondrial support and insulin sensitivity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAOD-9604\u003c\/td\u003e\n\u003ctd\u003eExperimental fat metabolism research\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eL-Carnitine\u003c\/td\u003e\n\u003ctd\u003eFatty acid transport into mitochondria\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNAD+ precursors (NMN or NR)\u003c\/td\u003e\n\u003ctd\u003eTheoretical support for NAD+ metabolism, though benefits with 5-Amino-1MQ are unproven\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003eDoes it pair well with GLP-1 medications?\u003c\/h3\u003e\n\u003cp\u003eThe combination that receives the most attention is:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTirzepatide + 5-Amino-1MQ\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eTirzepatide primarily reduces food intake.\u003c\/li\u003e\n\u003cli\u003e5-Amino-1MQ is hypothesized to increase energy expenditure and fat utilization.\u003c\/li\u003e\n\u003cli\u003eThere are no high-quality human trials showing that the combination is superior to tirzepatide alone.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eBottom line\u003c\/h3\u003e\n\u003cp\u003e5-Amino-1MQ is an \u003cstrong\u003eexperimental NNMT inhibitor\u003c\/strong\u003e being studied primarily for obesity, insulin resistance, fatty liver disease, and metabolic health. The scientific rationale is promising, but the evidence is still largely preclinical. It is commonly stacked in research settings with GLP-1 receptor agonists (such as Tirzepatide or Retatrutide), MOTS-c, Tesamorelin, and other body-composition-focused compounds, but the safety and effectiveness of these combinations have not been established in controlled human studies.\u003c\/p\u003e","brand":"Frontline Peptides","offers":[{"title":"5 MG","offer_id":51197284090079,"sku":null,"price":30.0,"currency_code":"USD","in_stock":true},{"title":"10 MG","offer_id":51197284122847,"sku":null,"price":40.0,"currency_code":"USD","in_stock":true},{"title":"50 MG","offer_id":51197284155615,"sku":null,"price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0807\/0810\/8511\/files\/5-AMINO-1MQ.png?v=1778953479","url":"https:\/\/frontlinepeptides.net\/products\/5-amino-1mq","provider":"Frontline Peptides","version":"1.0","type":"link"}